期刊文献+

增生性玻璃体视网膜病变基质金属蛋白酶的定量研究 被引量:7

A Quantitative Study of Matrix Metalloproteinases in Proliferative Vitreoretinopathy
在线阅读 下载PDF
导出
摘要 目的:研究增生性玻璃体视网膜病变(proliferative vitreoretinopathy,PVR)玻璃体中基质金属蛋白酶(matrix metalloproteinases,MMPs)的表达,探讨MMPs在PVR病理过程中的作用。方法:PVR患者采用标准三切口巩膜扁平部玻璃体切割术(pars plana vitrectomy,PPV),取未稀释的玻璃体21只眼,PPV术后复发的玻璃体腔液20只眼,意外死亡的正常人玻璃体10只眼,采用明胶酶谱分析法定量分析MMP-2和MMP-9活性水平。结果:PVR玻璃体有MMP-2活性水平增高,与正常玻璃体比较差异有显著性意义(P<0.05)。21眼PVR玻璃体中13只眼有MMP-9活性水平增高,平均(171.52±13.17)扫描单位。20眼PPV术后PVR复发的玻璃体腔液19只眼有MMP-9活性水平增高,平均(156.01±37.21)扫描单位。正常人玻璃体无MMP-9的表达。结论:PVR玻璃体有MMP-2和MMP-9活性水平增高,MMP-9活性水平增高可能与术后PVR复发有关。眼科学报2003;19:130-132。 Purpose: To investigate the presence of matrix metalloproteinases (MMPs) in vitreous of patients with proliferative vitreoretinopathy (PVR). To study MMPs involved in the pathogenesis of the PVR. Methods: Twenty-one PVR vitreous samples were from patients who were performed pars plana vitrectomy (PPV). Twenty vitreous liquid samples were from patients with postoperative recurrent PVR after PPV. Ten vitreous samples were normal group. The activities of MMP-2 and MMP-9 were determined by quantitative gelatinase zymogra-phy. Results: MMP-2 was detected in all of PVR and normal group. Vitreous samples were obtained, whereas MMP-9 was found in 13 of 21 vitreous with preoperative PVR, average (171.52±13.17)scanning units. MMP-9 was detected in 19 of 20 vitreous with postoperative recurrent PVR, average (156.01±37.21) scanning units. Conclusion: MMP-2 and MMP-9 were found in the vitreous of PVR. Elevated levels of MMP-9 may play a role in the development of postoperative PVR. Eye Science 2003; 19:130-132.
出处 《眼科学报》 2003年第2期130-132,共3页 Eye Science
关键词 增生性玻璃体视网膜病变 基质金属蛋白酶 发病机制 三切口巩膜扁平部玻璃体切割术 孔源性视网膜脱离 matrix metalloproteinases, vitreoretinopathy, proliferative, Vitreous, pathog-enic mechanisms
  • 相关文献

参考文献7

  • 1Tarlton JF, Vickery C J, Leaper D J, et al. Post surgical wound progression monitored by temporal changes in the expression of matrix metalloproteinases-9. Br J Dermatol 1997;137:506-516.
  • 2Agren MS. Gelatinase activity during wound healing. Br J Dermatol 1994;131:634-640.
  • 3Brown DJ,Bishop P, Himdi H, et al. Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2. Curr Eye Res 1995;15:439--45.
  • 4Brown D, Hamdi H, Bahri S, et al. Characterization of an endogenous metallopmteinase in human vitreous. Curr Eye Res 1994;13:639-647.
  • 5Abu E1-Asar AM,Geboes K, et al. Expression of gelatinase B in trachomatous conjunctivitis.Br J Ophthalmol 2000;84:85-91.
  • 6Kvanta A, Sarman S, Fagerholm P, et aL Expression of matrix metalloproteinase-2(MMP-2) and vascular endothelial growth factor (VEGF) in inflammtion associated corneal neovascularization. Exp Eye Res 2000,70:.419--428.
  • 7Plantner JJ, Jiang C, Mind, et al. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with agerelated maeular degeneration. Exp Eye Res 1998;67,637-645.

同被引文献77

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部